Change of Immune Cell of ARDS Patients：an Observational Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02958748

Enrollment

Registered

2016-11-08

Start date

2016-11-30

Completion date

Unknown

Last updated

2016-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS, Intensive Care Medicine

Brief summary

To evaluate change of different immune cellsduring ARDS and its impact on prognosis.

Interventions

OTHERtaking blood sample

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

16 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

①sign on the acknowledged ②Diagnosis with ARDS(The Berlin definition），onset within 48hours

Exclusion criteria

①diagnosis of hematological or immunological disease ②treatment with chemotherapy agents or corticosteroids within 6 months prior to or during the hospitalization.

Design outcomes

Primary

Measure	Time frame
mortality	28-day

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026